ClinicalTrials.gg
CompletedNCT04573985Updated Nov 18, 2023

Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder

An interventional study of Serious game Eurekoi intervention in Family Caregiver of Patient With Alzheimer Disease, sponsored by Centre Hospitalier Universitaire de Nice. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to assess the effectiveness of serious EUREKOI gambling on the anxiety of family caregivers of patients with newly diagnosed Alzheimer's disease.

02

Conditions studied

  • Family Caregiver of Patient With Alzheimer Disease
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 722 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men or women over 18 years old;
  • Primary caregiver of a patient with a mild-stage major neurocognitive disorder newly diagnosed according to the DSM 5 criteria;
  • Signature of informed consent.

Exclusion criteria

Exclusion Criteria:

  • Subject not speaking French, not reading French
  • Subject with visual impairment
  • Subject under tutorship or curatorship.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Serious Game Eurekoi intervention

    1 session in group using the serious game eurekoi

    Behavioral: Serious game Eurekoi intervention

  • No intervention
    Control group

    no intervention

Interventions

  • BehavioralSerious game Eurekoi intervention

    1 session in group using the serious game eurekoi

06

What researchers measure

Primary outcomes

  1. Efficacity of the serious game Eurekoi on anxiety of familial caregiver of patient with Alzheimer Disease

    Auto-evaluation of anxiety using Spielberger inventory (score between 20 and 80 ; the higher the score, the greater the anxiety)

    Time frame: 3 months

Secondary outcomes

  1. Change of knowledge of familial caregiver about cognitive troubles

    Multiple choice questionary

    Time frame: 3 months

  2. Evaluate satisfaction of the familial caregivers about the session with the game EUREKOI

    questionary of satisfaction

    Time frame: 3 months

07

Study locations

1 site
  • CHU de Nice
    Nice, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04573985
Responsible party
Sponsor
First posted
Oct 5, 2020
Start date
Dec 8, 2020
Primary completion
Sep 6, 2022
Completion
Sep 6, 2022
Last update
Nov 18, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion